Please wait while we open this resource.
K
Guidelines & protocols
Pharmacotherapy for Obesity Management: 2025 Guidelines
CMAJ
PDF202513 pages264 KB
This guideline update provides recommendations for clinicians on the efficacy, safety, and appropriate use of pharmacotherapy in the management of obesity in adults, including new and revised recommendations since the 2022 pharmacotherapy for obesity management revision.
No account needed
Ask this resource
Answers use this document only.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Uganda Diabetes Management Guidelines – Summarised (2026)
Same clinical topic · Endocrinology
Kiruddu DKA guidelines
Same clinical topic · Endocrinology
Management of DKA
Same clinical topic · Endocrinology
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY CONSENSUS STATEMENT ALGORITHM FOR MANAGEMENT OF ADULTS WITH TYPE 2 DIABETES — 2026 UPDATE
Same clinical topic · Endocrinology
GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CONGENITAL HYPOTHYROIDISM
Same clinical topic · Endocrinology
2026 ETA GUIDELINE ON INTERFERENCE IN IMMUNOASSAY MEASUREMENTS USED IN ASSESSMENT OF THYROID FUNCTION
Same clinical topic · Endocrinology
CANADIAN ADULT OBESITY CLINICAL PRACTICE GUIDELINE: PHARMACOTHERAPY FOR OBESITY MANAGEMENT IN ADULTS
Same clinical topic · Endocrinology
Nutritional Management of Diabetes SOP (2)
Same clinical topic · Endocrinology
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY CONSENSUS STATEMENT: COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2023 UPDATE
Same clinical topic · Endocrinology